Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01537939 · ClinicalTrials.gov registry record · Phase 4
ASUKI Step Pedometer Worksite Intervention
A Phase 4 study, sponsored by Arizona State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,018
- Enrollment target
NCT01537939: Completed Phase 4 study, sponsored by Arizona State University.
NCT01537939 is a Phase 4 study that has completed, run by Arizona State University. The registered enrollment target is 2,018 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (290% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01537939, a Phase 4 study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,018 participants
- Enrollment target
Study Summary
ASUKI Step is designed to increase the number of days employees walk 10,000 steps and to reduce the number of days employees spend being inactive. Study aims were: 1. to have a minimum of 400 employee participants from each university site reach a level of 10, 000 steps per day on at least 100 days (3.5 months) during the trial period; 2. to have 70% of the employee participants from each university site maintain two or fewer inactive days per week, defined as a level of less than 3,000 steps per day; 3. to describe the socio-demographic, psychosocial, environmental and health-related determinants of success in the intervention; and 4. to evaluate the effects of a pedometer-based walking intervention in a university setting on changes in self-perceived health and stress level, sleep patterns, anthropometric measures and fitness.
Primary Outcome
Tally of the participants recording 10,000 steps on their pedometer log for 100 days of the 6 month walking intervention.
Interventions
- BEHAVIORAL ASUKI Step Worksite Pedometer Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,018 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
What the finished NCT01537939 record still lists
NCT01537939 is an interventional study that assigns participants to a tested intervention. Its 2,018 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (290% higher).
The record links to 0 conditions, and to 1 intervention - of which ASUKI Step Worksite Pedometer Intervention is the first listed.
NCT01537939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01537939 about?
NCT01537939 is a clinical study titled "ASUKI Step Pedometer Worksite Intervention". ASUKI Step is designed to increase the number of days employees walk 10,000 steps and to reduce the number of days employees spend being inactive. Study aims were: 1. to have a minimum of 400 employee participants from each university site reach a level of 10, 000 steps per day on at least 100 day...
What is the current status of trial NCT01537939?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,018 participants. The study started on 2009-03. Estimated completion is 2009-12.
What interventions are being tested in trial NCT01537939?
The interventions under investigation include: ASUKI Step Worksite Pedometer Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01537939?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01537939's enrollment target sits among peer trials
2,018 36th of 2000 higher than 1,965 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia